Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC).
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Ethinylestradiol/etonogestrel (Primary) ; Oral contraceptives
- Indications Pregnancy
- Focus Adverse reactions
- Acronyms TASC
- 08 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Nov 2011 Planned end date changed from 1 Sep 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 12 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.